Van der Woude syndrome is a rare genetic disorder characterized by orofacial clefts and lower lip pits. It is estimated to affect approximately 1 in 35,000 to 1 in 100,000 individuals worldwide. The syndrome is inherited in an autosomal dominant manner, meaning that a child has a 50% chance of inheriting the condition if one parent is affected. While the prevalence may vary across different populations, it is generally considered to be a relatively uncommon condition.
Van der Woude syndrome is a rare genetic disorder characterized by orofacial clefts and lower lip pits. It is estimated to affect approximately 1 in 35,000 to 1 in 100,000 individuals worldwide. The prevalence of this syndrome varies among different populations and ethnic groups.
The syndrome is caused by mutations in the interferon regulatory factor 6 (IRF6) gene, which plays a crucial role in the development of the face and lip. These mutations can be inherited in an autosomal dominant pattern, meaning that an affected individual has a 50% chance of passing the condition on to their children.
Individuals with Van der Woude syndrome may present with a range of symptoms, including cleft lip and/or palate, lower lip pits, missing teeth, and other dental abnormalities. The severity of the condition can vary widely, even among affected family members.
Early diagnosis and appropriate management are essential for individuals with Van der Woude syndrome. Treatment typically involves a multidisciplinary approach, including surgical repair of the cleft lip and/or palate, dental interventions, and speech therapy.
While Van der Woude syndrome is considered rare, it is important to raise awareness about this condition to ensure timely diagnosis and support for affected individuals and their families.